Vincent Moretti, MD
Orthopaedic Surgery · Fort Worth, TXNPI 1326362864
Payments from drug & device makers
Across 73 payments — averaging $103.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Synthes GmbH$2K
- Zimmer Biomet$619
- Smith+Nephew$408
- Medical Device Business Services, Inc.$191
- Corentec America Inc$150
- plus $219 from 8 others
What the payments were for
- Speaking & faculty fees$1,50020%
- Travel & lodging$1,76823%
- Food & beverage$4,30057%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 43 | $4,375 |
| Synthes GmbH | 2 | $1,607 |
| Zimmer Biomet | 9 | $619 |
| Smith+Nephew | 7 | $408 |
| Medical Device Business Services, Inc. | 3 | $191 |
| Corentec America Inc | 1 | $150 |
| Globus Medical | 1 | $50 |
| Johnson & Johnson | 1 | $36 |
| Acera Surgical, Inc. | 1 | $29 |
| Molnlycke Health Care US, LLC | 1 | $27 |
| Vertex | 1 | $22 |
| DJO, LLC | 1 | $21 |
| UOC USA Inc | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,964
- ACCOLADE$1,078
- ROSA$152
- Corentec$150
- REAL INTELLIGENCE$149
- Legion$147
- Navio Surgical System$147
- PICO 7 Single Use Negative Pressure Wound Therapy$147
- REGENESORB$147
- Persona$144
- SURGICEL NU-KNIT$127
- Echo$124
How this compares
$7,569 in reported general payments places this provider in the 55th percentile of 1,337 orthopaedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 29 | $1,527 |
| Celecoxib | 58 | $1,396 |
| Diclofenac Sodium | 18 | $511 |
| Gabapentin | 59 | $404 |
| Oxycodone Hcl | 48 | $317 |
| Tramadol Hcl | 58 | $245 |
| Cefadroxil | 36 | $210 |
| Meloxicam | 58 | $123 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Fort Worth
- Robert SchmidtFort Worth$2M
- Stephen BurkhartSan Antonio$185.3M
- Kirby HittTemple$9.1M
- J Richard EvansonPlano$8.1M
- Stefan KreuzerHouston$7M
- Robert GrahamAustin$6.3M
- Richard JonesDallas$6.3M
- Howard HarrisBedford$4.6M
- Tiffany HuynhHouston$4.6M
- Michael WirthSan Antonio$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.